Aurinia Pharmaceuticals Receives Notice Regarding USPTO Trial And Appeal Board Decision To Institute Trial On Inter Partes Review Filed By Sun Pharmaceuticals
Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) ("Aurinia" or the "Company") today received notice regarding the U.S. Patent Office (USPTO) Patent Trial and Appeal Board (PTAB) decision to institute trial